Partner Headlines - ECTE

  1. Echo Therapeutics Comments on Proxy Contest by Platinum Management ...

    Benzinga
  2. Platinum Management (NY) LLC Urges Stockholders to Take No Action ...

    Benzinga
  3. Echo Therapeutics Submits CE Mark Technical File to European ...

    Benzinga
  4. Morning Market Losers

    Benzinga
  5. Morning Market Movers

    Benzinga
  6. Echo Therapeutics Schedules Meeting with Platinum-Montaur Next ...

    Benzinga
  7. Echo Therapeutics Announces CEO, President and Chairman, Dr. ...

    Benzinga
  8. LifeTech Capital Reiterates Neutral Rating on Echo Therapeutics ...

    Benzinga
  9. Echo Therapeutics Prices 13.33M Share Offering @ $0.75/Share

    Benzinga
  10. Echo Therapeutics to Report Trial Results of Symphony tCGM System ...

    Benzinga
  11. Echo Therapeutics Prices 3.2M Share Offering @$0.95/Share

    Benzinga
  12. Stocks Hitting 52-Week Lows

    Benzinga
  13. Stocks Hitting 52-Week Lows

    Benzinga
  14. Echo Therapeutics Announces Proposed Public Offering

    Benzinga
  15. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur ...

    Benzinga
  16. Benzinga's Top Initiations

    Benzinga
  17. Echo Therapeutics Announces Positive Clinical Trial Results of ...

    Benzinga
  18. UPDATE: Wunderlich Securities Initiates Coverage of Echo Therapeutics ...

    Benzinga
  19. Echo Therapeutics Expands License Agreement with Ferndale Pharma

    Benzinga
  20. Echo Therapeutics Presents Positive Clinical Trial Results of ...

    Benzinga
  21. Benzinga's Top Downgrades With Color for May 14, 2012

    Benzinga
  22. Echo Therapeutics Announces Positive Clinical Trial Results of ...

    Benzinga
  23. Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM ...

    Benzinga
  24. LifeTech Has Strong Speculative Buy, $6 PT On Echo Therapeutics

    Benzinga
Trading Center